Bodisen Biotech (LSE:BODI) Capital Expenditure : £0.00 Mil (TTM As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Bodisen Biotech's cash flow for capital expenditures for the three months ended in Jun. 2013 was £0.00 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2013 was £0.00 Mil.

Bodisen Biotech Capital Expenditure Historical Data

The historical data trend for Bodisen Biotech's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Capital Expenditure Chart

Bodisen Biotech Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Capital Expenditure

Get a 7-Day Free Trial

-6.39

-0.01

-0.36

-0.01

Bodisen Biotech Quarterly Data
	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Jun13
Capital Expenditure	Get a 7-Day Free Trial															-0.01	-0.01	-	-	-

Bodisen Biotech Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was £0.00 Mil.